Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin in Transient Insomnia
NCT00666770Phase 3Completed
- Sponsor
- Viatris
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gabapentin in Insomnia (3 arms), sponsored by Viatris. Primary endpoint: Latency to Persistent Sleep. Started Oct 2004; status: completed.
02
Drugs
gabapentin
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00666770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00666770.